Reviews/Electrolytes and Hydration/Electrolyte drinks reduce cramps
Cramps · EHYD-CRA-02 · v2
Two small randomised trials in this corpus both point the same way: electrolyte drinks appear to help with muscle cramps more than water. In the one study that actually tested how easily a cramp could be triggered, people were slightly harder to cramp after an electrolyte drink than after a near-water placebo [1]. A second trial found that sips of an electrolyte brine eased how bad cramps felt compared with tap water, but in patients with liver cirrhosis [3]. Both studies are small and narrow: the first had only nine people and the effect was tiny and did not stop anyone cramping, and its active drink also contained calories from carbohydrate, so the benefit cannot be pinned cleanly on electrolytes. The second measured how severe a cramp was once it started, not how likely a cramp was in the first place. The direction of the claim is supported, but by thin and off-target evidence, which is why the panel did not treat it as settled.
The corpus contains exactly two trials that bear on electrolyte-drink-versus-water for cramps. In [1], a nine-person crossover, the electrically induced cramp threshold frequency was higher on the electrolyte beverage (14.86 ± 7.47 Hz) than the near-water placebo (14.00 ± 5.03 Hz; P = .038), and reported pain was lower (2.0 ± 0.6 vs 2.7 ± 0.8; P = .025). In [3], a randomised trial of 82 cirrhotic patients, sips of pickle brine at cramp onset reduced cramp severity on a 0–10 scale (-2.25 ± 3.61) versus tap water (-0.36 ± 2.87; P = 0.03). Both findings favour the electrolyte arm, so the direction of the claim is consistently supported. No large trial of exercise-associated cramp testing an electrolyte drink against water is present. The contested point: The division is over whether these two trials establish a reduction in cramp susceptibility or merely gesture at it. [1] tests susceptibility directly but is N=9, with a ~0.9 Hz shift that did not prevent cramping in any participant and an active drink confounded by 120 kCal of carbohydrate; [3] tests severity at onset, not susceptibility, in a disease-specific population.
All 12 papers behind this claim with their DOIs and what each does to it, the panel’s arbitration, the evidence gap map and the open research questions. Free, and sent to your inbox.
We’ll also send you other claims from Electrolytes and Hydration, one at a time, and tell you when a release or a pivotal trial changes a grade. Unsubscribe by replying.
One reviewer's only job is to attack the finding. The challenges below were weighed before the grade was set.
[1] is a 9-participant crossover and the threshold difference is small (14.86 vs 14.00 Hz) and did not prevent cramping in any participant — a statistically significant but clinically modest shift in susceptibility.
[3] measures cramp severity change at onset (an abortive effect), not cramp susceptibility, so it does not test the exact claim wording.
Where it remains uncertain. The only direct susceptibility evidence [1] is N=9, small, and carbohydrate-confounded, while the corroborating trial [3] measures severity at onset in cirrhotic patients rather than susceptibility in the general population.
Aleatory
[1] is N=9 with large standard deviations around the threshold values (±7.47 and ±5.03 Hz), so the small mean difference carries substantial sampling noise.
Epistemic
The corpus holds no large exercise-associated-cramp trial comparing an electrolyte drink with water; [1] itself notes recent work questioning the electrolyte-cramp link.
Inferential
[3] measures cramp severity change at onset, an abortive effect, and is read as support for a susceptibility claim it does not directly test.
The load-bearing papers from a corpus of 12, each classified by what it does to the claim. Every DOI is taken from the corpus the claim was graded on.
Direct test of the claim: electrolyte beverage raised the cramp threshold frequency (lower susceptibility) versus a near-water placebo.
“EB consumption decreased cramp susceptibility and pain but did not prevent cramping in any participants.”
Panel auditInternal validity: medium · scope of inference: Young, euhydrated, cramp-prone people undergoing electrically induced cramp, comparing an electrolyte beverage to a minimal-electrolyte placebo beverage.Key limitations: very small sample · electrically induced (not spontaneous) cramp · comparator is a placebo beverage, not plain water · no participant was prevented from cramping
Corroborating direction against a true tap-water comparator: an electrolyte brine reduced cramp severity more than water, though on a severity (not susceptibility) endpoint in cirrhosis.
“the respective values for the pickle juice and control arms were -2.25 ± 3.61 points on the VAS for cramps, compared with control tap water (-0.36 ± 2.87), P = 0.03”
Panel auditInternal validity: medium · scope of inference: Patients with cirrhosis and frequent muscle cramps, taking a brine versus tap water at cramp onset.Key limitations: cirrhosis-specific population · outcome is cramp severity not susceptibility · open-label · pickle brine is not a typical electrolyte sports drink · background cramp therapies present
2 of 12 papers shown. The full review lists all of them, with the panel’s arbitration →
Claims are graded at each quarterly release, and re-graded between releases only when a pivotal trial lands. Every change is a new version of the claim.
The claim's direction is consistently supported, but by two small, narrow trials with surrogate or off-target endpoints, so the corpus carries the direction but not a robust magnitude.
Release 2026-q4 re-graded every claim from its corpus under protocol v0.19. An earlier release's grade is shown for the record; it came from an earlier protocol and is not a movement.
Assumptions that carry weight but are not themselves established.
The panel records the gap that would most move the claim, and the study that would close it.
No large electrolyte-drink-vs-water susceptibility RCT. The only direct susceptibility evidence is a nine-person crossover [1]; magnitude and generalisability are unestablished. The panel rates this the highest-importance open gap for the claim, and names the study design that would close it: An adequately powered randomised trial in cramp-prone general-population or athletic participants comparing an electrolyte drink with plain water, with cramp threshold frequency as the primary endpoint.
Open question: Does an electrolyte drink reduce the likelihood of cramping, not just the severity of a cramp once it starts, compared with water? Why it is still open: The only direct susceptibility measure [1] is N=9, and the corroborating trial [3] measures severity at onset rather than susceptibility.
Priors is a sceptical first reader, not peer review, and not medical advice.
Release 2026-q4 · graded 21 Oct 2026 · protocol v0.19